Multiple Myeloma (MM) is a hematologic malignancy characterized by the proliferation of
monoclonal plasma cells localized within the bone marrow. Bone disease with associated …

Multiple myeloma is a hematologic malignancy of plasma cells that causes bone-destructive
lesions and associated skeletal-related events (SREs). The pathogenesis of myeloma …

Multiple myeloma is an incurable plasma B-cell malignancy with 5-year survival rates
approximately 10-30% lower than other hematologic cancers. Treatment options include …

Most patients with multiple myeloma (MM) suffer from chronic pain at every stage of the
natural disease process. This review focuses on the most common causes of chronic pain in …

Identifying MRI-based radiomics features capable to assess response to systemic treatment
in multiple myeloma (MM) patients. Retrospective analysis of whole-body MR-image data in …

Multiple myeloma (MM) is the second‐ranking malignancy in hematological tumors. The
pathogenesis of MM is complex with high heterogeneity, and the development of the …

Multiple myeloma (MM) progression and myeloma-associated bone disease (MBD) are
highly dependent on bone marrow mesenchymal stromal cells (MSCs). MM-MSCs exhibit …

Osteoporotic vertebral fractures signify an increased risk of future fractures and mortality and
can manifest the diagnosis of osteoporosis. We investigated the prevalence of vertebral …

Spinal cord compression caused by cancer metastasis is a medical emergency that should
be managed positively. Both multiple myeloma and lung cancer can lead to metastatic …

Multiple myeloma (MM) is the second common hematologic malignancy manifesting as a
clonal proliferation of plasma cells in the bone marrow. In recent years, high expression and …